Brief: Standard Biotools Announces Agreement To Sell Microfluidics Business To Archimed
05/10/2026 22:52
BRIEF-Standard Biotools Announces Agreement To Sell Microfluidics Business To Archimed Oct 5 (Reuters) - Standard BioTools Inc. LAB.O:
STANDARD BIOTOOLS ANNOUNCES AGREEMENT TO SELL MICROFLUIDICS BUSINESS TO ARCHIMED
STANDARD BIOTOOLS - DEAL EXPECTED TO CLOSE IN ABOUT 30 DAYS
STANDARD BIOTOOLS INC.: UNTIL CLOSING OF DEAL, MICROFLUIDICS BUSINESS WILL CONTINUE TO OPERATE AS PART OF STANDARD BIOTOOLS.
Source text: ID:nGNX38B37D
Further company coverage: LAB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Standard BioTools
See all newsBrief: Standard Biotools Announces Agreement To Sell Microfluidics Business To Archimed
Brief: Standard Biotools Provides Update On Sale Of Mass Cytometry Business
Standard BioTools Inc. reports results for the quarter ended June 30 - Earnings Summary
Standard BioTools Q2 revenue falls on consumables weakness
Brief: Standard BioTools Q2 EPS USD -0.07